Journal Articles and Book Chapters
Cohn AL, Taberno J, Maurel J, Nowara E, Sastre J, Chuah BYS, Kopp MV, Sakaeva DD, Mitchell EP, Dubey S, Suzuki S, Hei Y, Galimi F, McCaffery I, Pan Y, Loberg R, Cottrell S, Choo SP. A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer. Annals of Oncology. 2013; 24:1777-85.
Paz-Ares L, Balint B, de Boer RH, van Meerbeeck JP, Wierzbicki R, De Souza P, Galimi F, Haddad V, Sabin T, Hei Y, Pan Y, Cottrell S, Hsu C, Ramlau R. A randomized phase 2 Study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer. J Thoracic Oncology. 2013; 8:329-37.
Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, Gardiner J, Garnero P, Hardin J, Henrotin Y, Heinegård D, Ko A, Lohmander LS, Matthews G, Menetski J, Moskowitz R, Persiani S, Poole AR, Rousseau JC, Todman M. OARSI FDA Osteoarthritis Biomarkers Working Group. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage. 2011; 19:515-42.
Weiss G, Cottrell S, Distler J, Schatz P, Kristiansen G, Ittmann M, Haefliger C, Lesche R, Hartmann A, Corman J, Wheeler T. DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. J Urol. 2009; 181:1678-85.
Cottrell S, deVos T, Distler J, Haefliger C, Lesche R, Plum A, Schuster M. DNA methylation analysis: Providing new insight into human disease. In Ginsburg G and Willard H, ed. Genomic and Personalized Medicine. Cambridge, Massachusetts: Elsevier; 2008: 131-142.
Cottrell S, Jung K, Kristiansen G, Eltze E, Semjonow A, Ittmann M, Hartmann A, Stamey T, Haefliger C, Weiss G. Discovery and validation of three novel DNA methylation markers of prostate cancer prognosis. J Urol. 2007; 177:1753-8.
Cottrell S. Molecular diagnostic applications of DNA methylation technology. Clin Laboratory International. 2005; 29:18-21.
Cottrell SE. Molecular diagnostic applications of DNA methylation technology. Clin Biochem. 2004; 37:595-604.
Cottrell S, Distler J, Goodman N, Mooney S, Kluth A, Olek A, Schwope I, Tetzner R, Ziebarth H, Berlin K. A real-time PCR assay for DNA-methylation using methylation-specific blockers. Nucleic Acids Res. 2004; 32:e10.
Cottrell S, Laird P. Sensitive detection of DNA methylation. Ann N Y Acad Sci. 2003; 983:120-30.
Cottrell SE. Analysis and applications of DNA methylation-based tumor markers. J Clinical Ligand Assay Soc. 2002; 25: 212-214.
Pawlikowska L Cottrell SE, Harms MB, Li Y, Rosenberg PA. Extracellular synthesis of cADP-ribose from nicotinamide-adenine dinucleotide by rat cortical astrocytes in culture. J Neuroscience. 1996; 16:5372-81.
Presentations
“Methylated DNA in tissue and serum of cancer patients” Tumor Markers: Discovery to Practice, Santa Barbara, CA 2003.
“Methylated DNA as cancer markers” Clinical Ligand Assay Society Annual Meeting, Houston, TX 2002.
“The development of sensitive, methylation-based, diagnostic marker panels” Oakridge Conference: Cancer Detection and Monitoring, La Jolla, CA 2002.
“The development of methylation-based cancer diagnostic marker panels” Epigenetics in Cancer Prevention Workshop, Bethesda, MD 2001.
Posters/Abstracts
Pan Y, Haddad V, Sabin T, Baker N, Hei Y, Galimi F, Graves J, Huang C, Cottrell S. “Predictive value of Fc gamma receptor IIIa genotype in response to conatumumab in three phase II studies.” American Society of Clinical Oncology Annual Meeting, Chicago, 2011.
Cottrell S, Huang C-P, Young L, Dell’aringa J, Pan Y. “Development and validation of genotyping assays for functional SNPs in the FC gamma receptor family genes.” American Society of Human Genetics Annual Meeting, Washington DC, 2010.
Wall J, Thor C, Cottrell S, Rand H, Branstetter D, Pan Y. “Evaluation of c-FLIP(long), c-FLIP(short), and Caspase 8 expression in primary tumors using a semi-quantitative multiplex LSC-based assay.” American Assocation for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development, Houston, 2010.
Gorski K, Sitko J, Thomas J, Gavin M, Cottrell S, Cox C, Vincent M, Ferbas J. “CCR4 improves phenotypic identification of T-regulatory cells; Validation and implementation of clinical test.” American Association of Immunologists Annual Meeting, Baltimore, 2010.
Payne S, Day J, Cottrell S, deVos T, Yamamura S, Lograsso J, Sarroza D, O'Campo Y, Morotti A, Sledziewski A. “Urine is a superior remote body fluid for early identification of prostate cancer using real-time PCR detection of DNA methylation markers.” ECCO - the European Cancer Conference, Barcelona, Spain 2007.
Cottrell S, Weiss G, Stamey T, Nolley R, Wheeler T, Ittmann M, Corman J, Odom E, Dahl K, Haefliger C, Sledziewski A. “Methylation markers are an independent measure of prostate cancer prognosis in a cohort of 605 radical prostatectomy patients.” American Association for Cancer Research Annual Meeting, Washington, DC, 2006.
Cottrell S, Thomas J, Skillman T, Jung K, Dietel M, Kristiansen G, Ringsdorf M, Eltze E, Semjonow A, Stamey T, Ittmann M, Haefliger C, Sledziewski A. “Genome-wide discovery and validation of sites of aberrant methylation associated with prostate cancer prognosis.” NCI SPORE Investigator’s Meeting, Washington, DC, 2005.
Cottrell S, Thomas J, Jung K, Dietel M, Kristiansen G, Ringsdorf M, Eltze E, Semjonow A, Haefliger C, Sledziewski A. “Discovery and validation of DNA methylation based markers of prostate cancer prognosis.” Association for Cancer Research Annual Meeting, Anaheim, 2005.
Cottrell S, Goodman N, Mooney S, Sledziewski A. “Analysis of two methylated sequences in colon cancer tissue and serum samples.” Association for Cancer Research Annual Meeting, Washington, DC, 2003.
Cottrell S, Mooney S, Lofton-Day C, Laird P, Berlin K, Distler J, Sledziewski A. “The development of sensitive, methylation-based, diagnostic marker panels.” Gordon Research Conference: New Frontiers in Cancer Diagnostics, Ventura, CA, 2002.
Cottrell S, Mooney S, Sledziewski A, Laird P. “Application of DNA methylation technology for the early detection of cancer.” International Association for the Study of Lung Cancer Annual Meeting, Reykjavik, Iceland, 2001.
Cottrell S, Mooney S, Sledziewski A, Laird P. “Application of DNA methylation technology for the early detection of cancer.” Early Detection Research Network meeting, Seattle, 2001.